Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lipocine (LPCN) Return on Invested Capital (2016 - 2025)

Lipocine (LPCN) has disclosed Return on Invested Capital for 12 consecutive years, with 0.33% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Invested Capital fell 7.0% year-over-year to 0.33%, compared with a TTM value of 0.33% through Sep 2025, down 7.0%, and an annual FY2024 reading of 0.0%, up 64.0% over the prior year.
  • Return on Invested Capital was 0.33% for Q3 2025 at Lipocine, down from 0.24% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.0% in Q4 2024 and bottomed at 0.84% in Q4 2023.
  • Average Return on Invested Capital over 5 years is 0.32%, with a median of 0.33% recorded in 2022.
  • The sharpest move saw Return on Invested Capital skyrocketed 99bps in 2021, then plummeted -70bps in 2023.
  • Year by year, Return on Invested Capital stood at 0.0% in 2021, then plummeted by -10148bps to 0.33% in 2022, then crashed by -153bps to 0.84% in 2023, then soared by 100bps to 0.0% in 2024, then plummeted by -376609bps to 0.33% in 2025.
  • Business Quant data shows Return on Invested Capital for LPCN at 0.33% in Q3 2025, 0.24% in Q2 2025, and 0.26% in Q1 2025.